Introduction
The pharmaceutical industry wields extraordinary power over human health, controlling the development, pricing, and distribution of the medicines upon which billions of lives depend. Yet this power has too often been exercised in pursuit of profit at the expense of patient welfare, public health, and equitable access. This essay argues that the pharmaceutical industry should be more tightly regulated, as the existing regulatory framework has proven insufficient to prevent price gouging, the suppression of unfavourable research, and the prioritisation of profitable drugs over those most needed by the global population.
The pharmaceutical industry's pricing practices exploit patients and healthcare systems, necessitating tighter regulation to ensure affordable access to essential medicines.
Explain
Pharmaceutical companies routinely charge prices that bear no rational relationship to the cost of drug development or production, leveraging patent monopolies and inelastic demand to extract maximum revenue from patients who have no alternative. This pricing behaviour is not merely ethically troubling but constitutes a systemic threat to healthcare affordability, forcing patients to choose between financial ruin and forgoing treatment. Tighter price regulation is necessary to ensure that the fruits of pharmaceutical innovation are accessible to all who need them, not just those who can afford to pay.
Example
An estimated 1.3 million Americans have reported rationing their insulin due to cost, according to surveys and media inv…
Introduction
While legitimate concerns exist about pharmaceutical industry practices, the call for tighter regulation risks stifling the innovation that has given humanity antibiotics, vaccines, and treatments for previously incurable diseases. The pharmaceutical industry operates in one of the most heavily regulated environments of any sector, and additional regulatory burdens threaten to increase drug development costs, delay life-saving treatments, and deter the private investment that funds the vast majority of medical research. This essay contends that the pharmaceutical industry should not be more tightly regulated, and that existing frameworks, complemented by targeted reforms, are sufficient to address legitimate concerns.
The pharmaceutical industry is already one of the most heavily regulated sectors in the world, and additional regulation risks stifling the innovation that produces life-saving drugs.
Explain
Drug development is an extraordinarily expensive, time-consuming, and risky endeavour. It takes an average of 10 to 15 years and over $2 billion to bring a new drug from initial discovery to market approval, with a success rate of less than 10% for drugs entering clinical trials. The existing regulatory framework, including the rigorous approval processes of the US FDA, the European Medicines Agency, and Singapore's Health Sciences Authority, already imposes substantial compliance costs. Further tightening this framework would increase the cost and time required for drug development, potentially deterring private investment and ultimately reducing the number of new treatments available to patients.
Example
The rapid development of COVID-19 vaccines in 2020, with Pfizer-BioNTech and Moderna delivering effective mRNA vaccines …
How far should governments be responsible for the health of their citizens?
2024'The key to good health is lifestyle rather than medicine.' How far do you agree?
2013'Mental health is just as important as physical health.' How far has society accepted this view?
2021Should governments have the right to impose health-related restrictions on individuals?
2020'The healthcare system benefits the rich more than the poor.' Discuss.
2017